ClinicalTrials.gov record
Afatinib Expanded Access Program
ClinicalTrials.gov ID: NCT01649284
Public ClinicalTrials.gov record NCT01649284. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
LUX-Lung EAP US; An Open Label Expanded Access Program of Afatinib (BIBW 2992) for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, multi-center, single-arm trial, designed to provide early access to afatinib and to provide additional information on the safety and efficacy of afatinib in advanced NSCLC patients who harbor an EGFR mutation.
Study identification
- NCT ID
- NCT01649284
- Recruitment status
- Approved For Marketing
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2012 (Type not available)
- Primary completion
- Mar 2014 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- Nov 30, 2016
2012 – 2014
United States locations
- U.S. sites
- 66
- U.S. states
- 33
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1200.45.004 Boehringer Ingelheim Investigational Site | Mobile | Alabama | — | — |
| 1200.45.116 Boehringer Ingelheim Investigational Site | Goodyear | Arizona | — | — |
| 1200.45.057 Boehringer Ingelheim Investigational Site | Hot Springs | Arkansas | — | — |
| 1200.45.078 Boehringer Ingelheim Investigational Site | Anaheim | California | — | — |
| 1200.45.114 Boehringer Ingelheim Investigational Site | Burbank | California | — | — |
| 1200.45.123 Boehringer Ingelheim Investigational Site | Glendale | California | — | — |
| 1200.45.115 Boehringer Ingelheim Investigational Site | Lakewood | California | — | — |
| 1200.45.117 Boehringer Ingelheim Investigational Site | Long Beach | California | — | — |
| 1200.45.102 Boehringer Ingelheim Investigational Site | Monterey | California | — | — |
| 1200.45.091 Boehringer Ingelheim Investigational Site | Pleasant Hill | California | — | — |
| 1200.45.098 Boehringer Ingelheim Investigational Site | Pleasant Hill | California | — | — |
| 1200.45.006 Boehringer Ingelheim Investigational Site | Ranco Cucamonga | California | — | — |
| 1200.45.003 Boehringer Ingelheim Investigational Site | Southington | Connecticut | — | — |
| 1200.45.007 Boehringer Ingelheim Investigational Site | Stamford | Connecticut | — | — |
| 1200.45.026 Boehringer Ingelheim Investigational Site | Hollywood | Florida | — | — |
| 1200.45.097 Boehringer Ingelheim Investigational Site | Hollywood | Florida | — | — |
| 1200.45.017 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | — | — |
| 1200.45.058 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | — | — |
| 1200.45.016 Boehringer Ingelheim Investigational Site | Lakeland | Florida | — | — |
| 1200.45.103 Boehringer Ingelheim Investigational Site | Miami Beach | Florida | — | — |
| 1200.45.037 Boehringer Ingelheim Investigational Site | Orlando | Florida | — | — |
| 1200.45.056 Boehringer Ingelheim Investigational Site | Port Saint Lucie | Florida | — | — |
| 1200.45.119 Boehringer Ingelheim Investigational Site | Titusville | Florida | — | — |
| 1200.45.095 Boehringer Ingelheim Investigational Site | Alpharetta | Georgia | — | — |
| 1200.45.029 Boehringer Ingelheim Investigational Site | Athens | Georgia | — | — |
| 1200.45.042 Boehringer Ingelheim Investigational Site | Macon | Georgia | — | — |
| 1200.45.121 Boehringer Ingelheim Investigational Site | Valdosta | Georgia | — | — |
| 1200.45.024 Boehringer Ingelheim Investigational Site | Decatur | Illinois | — | — |
| 1200.45.009 Boehringer Ingelheim Investigational Site | Evanston | Illinois | — | — |
| 1200.45.099 Boehringer Ingelheim Investigational Site | Peoria | Illinois | — | — |
| 1200.45.040 Boehringer Ingelheim Investigational Site | Waterloo | Iowa | — | — |
| 1200.45.041 Boehringer Ingelheim Investigational Site | Wichita | Kansas | — | — |
| 1200.45.083 Boehringer Ingelheim Investigational Site | Marrero | Louisiana | — | — |
| 1200.45.087 Boehringer Ingelheim Investigational Site | Metairie | Louisiana | — | — |
| 1200.45.019 Boehringer Ingelheim Investigational Site | Columbia | Maryland | — | — |
| 1200.45.039 Boehringer Ingelheim Investigational Site | Rockville | Maryland | — | — |
| 1200.45.053 Boehringer Ingelheim Investigational Site | Ann Arbor | Michigan | — | — |
| 1200.45.046 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 1200.45.100 Boehringer Ingelheim Investigational Site | Jackson | Mississippi | — | — |
| 1200.45.067 Boehringer Ingelheim Investigational Site | St Louis | Missouri | — | — |
| 1200.45.071 Boehringer Ingelheim Investigational Site | Billings | Montana | — | — |
| 1200.45.021 Boehringer Ingelheim Investigational Site | Omaha | Nebraska | — | — |
| 1200.45.066 Boehringer Ingelheim Investigational Site | Freehold | New Jersey | — | — |
| 1200.45.105 Boehringer Ingelheim Investigational Site | Albuquerque | New Mexico | — | — |
| 1200.45.080 Boehringer Ingelheim Investigational Site | Brooklyn | New York | — | — |
| 1200.45.068 Boehringer Ingelheim Investigational Site | Fresh Meadows | New York | — | — |
| 1200.45.051 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1200.45.092 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1200.45.001 Boehringer Ingelheim Investigational Site | Charlotte | North Carolina | — | — |
| 1200.45.086 Boehringer Ingelheim Investigational Site | Bismarck | North Dakota | — | — |
| 1200.45.048 Boehringer Ingelheim Investigational Site | Minot | North Dakota | — | — |
| 1200.45.090 Boehringer Ingelheim Investigational Site | Canton | Ohio | — | — |
| 1200.45.005 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 1200.45.089 Boehringer Ingelheim Investigational Site | Tulsa | Oklahoma | — | — |
| 1200.45.094 Boehringer Ingelheim Investigational Site | Portland | Oregon | — | — |
| 1200.45.020 Boehringer Ingelheim Investigational Site | Hershey | Pennsylvania | — | — |
| 1200.45.096 Boehringer Ingelheim Investigational Site | Johnstown | Pennsylvania | — | — |
| 1200.45.060 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 1200.45.085 Boehringer Ingelheim Investigational Site | Pottstown | Pennsylvania | — | — |
| 1200.45.120 Boehringer Ingelheim Investigational Site | Rapid City | South Dakota | — | — |
| 1200.45.049 Boehringer Ingelheim Investigational Site | Cookeville | Tennessee | — | — |
| 1200.45.113 Boehringer Ingelheim Investigational Site | El Paso | Texas | — | — |
| 1200.45.045 Boehringer Ingelheim Investigational Site | Fairfax | Virginia | — | — |
| 1200.45.076 Boehringer Ingelheim Investigational Site | Seattle | Washington | — | — |
| 1200.45.093 Boehringer Ingelheim Investigational Site | Charleston | West Virginia | — | — |
| 1200.45.125 Boehringer Ingelheim Investigational Site | Wausau | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01649284, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 30, 2016 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01649284 live on ClinicalTrials.gov.